tiprankstipranks
Love Pharma Inc (TSE:JOLT)
:JOLT
Canadian Market

Love Pharma Inc (JOLT) Income Statement

Compare
7 Followers

Love Pharma Inc Income Statement

Last quarter (Q3 2024), Love Pharma Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Love Pharma Inc's net income was $-69.31K. See Love Pharma Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Sep 20Sep 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ 36.90K$ ―$ ―
EBITDA
$ -748.52K$ -3.56M$ -9.47M$ -128.30K$ -329.88K
Operating Income
$ -415.74K$ -1.66M$ -8.24M$ -128.30K$ -329.88K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -765.74K$ -3.58M$ -9.52M$ -128.30K$ -329.88K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Love Pharma Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis